Leadership Team

Jack Hoppin, Ph.D.
Chairman, Chief Executive Officer
Konica Minolta Precision Medicine (President), Invicro (Co-Founder), Emit Imaging (Co-Founder, Chairman)

John Babich, Ph.D.
Director, President, Chief Scientific Officer
Weill Cornell Medicine, Molecular Insight Pharmaceuticals (Co-Founder), MGH/HMS, RMH/ICR, NASA, BNL

Marc Becker, M.B.A, CPA
Chief Financial and Operating Officer
KPMG, BankBoston (now Bank of America), Genzyme, rEVO Biologics, CRISPR Therapeutics, Concert Pharmaceuticals, Flagship Pioneering

William Cupelo, M.B.A, M.S.
Chief Business Officer
Invicro

Matthias Friebe, Ph.D.
Chief Technology Officer
Piramal Imaging, Bayer AG, Schering AG, Harvard Medical School, Swiss Federal Institute of Technology

Scott Holbrook
Chief Commercial and Manufacturing Officer
Pharmalogic, Adjunct Assistant Professor University of Utah, Co-Founder Invivo Molecular Imaging and Precision Nuclear

Jacob Hesterman, Ph.D.
Chief Data Officer
Realm IDx, Invicro, Beth Israel Deaconess Medical Center, Bioscan, Inc

Alejandro Amor Coarasa, Ph.D.
Head of Radiochemistry
Albert Einstein College of Medicine, Weill Cornell Medicine, Florida International University

Stephen DiMagno, Ph.D.
Head of Discovery
UIC Pharmaceutical Sciences (Head), Ikaria (Co-founder), Osteoanalgesia, University of Nebraska, Ground Fluor Pharmaceuticals (Co-Founder), University of Pennsylvania, UC Berkeley

Shawn Hillier, Ph.D.
Executive Vice President and Head of Preclinical Development
Symbiotix Biotherapies, Moderna Therapeutics, Vertex Pharmaceuticals, Molecular Insight Pharmaceuticals, MIT

Scott MacDonald, J.D., M.B.A
Vice President, Head of Legal
Voyager Therapeutics, Foundation Medicine

John Marquis, Ph.D.
Vice President of Biology
Merck & Co., Molecular Insight Pharmaceuticals, MIT, Harvard

Kelly Orcutt, Ph.D.
Head of Quantitative Sciences
Viewpoint Molecular Targeting, Invicro, University of Iowa, Harvard Medical School, MIT

Christine Redmond
Vice President, Clinical Operations and Program Management
Bill and Melinda Gates Medical Research Institute, Biogen, Synta Pharmaceuticals, Lantheus Medical Imaging, Molecular Insight, Dyax, Acorda Therapeutics

William “Mo” Cowan, J.D.
Director
Former United States Senator, President, Global Government Affairs & Policy, General Electric Co., Chief Legal & External Affairs Officer, Devoted Health, Inc., Duke University, Northeastern University School of Law

Allan Green, M.D., Ph.D., J.D.
Director & Regulatory Consultant
Ground Fluor Pharmaceuticals, Atreus Pharmaceuticals, Theseus Imaging, NASI, NEN, Boston College Law School

Al Holman
Director
Founder and Co-Managing Partner, Chestnut Partners, Inc. Trustee and Chair of Finance Committee, Mass General Brigham

Susan K. Whoriskey, Ph.D.
Director
Founding Executive Team of Vera Therapeutics, Moderna, Momenta Pharmaceuticals, Cubist Pharmaceuticals
